In the last two years, our team members have advised 69% of the members of European Federation of Pharmaceutical Industries and Associations (EFPIA) and 63% of the members of Danish Association of the Pharmaceutical Industry (LIF), which demonstrates our deep engagement and trust within the pharmaceutical industry both at European and national level.
We are proud to advise innovative life sciences companies — both internationally and nationally — on a wide range of matters including on:
This broad experience enables us to deliver results aligned with the strategic and operational priorities of both global and Danish clients.